Biomimetic Nanotechnology for SARS-CoV-2 Treatment DOI Creative Commons
Shuo Li, Xue Liu, Gang Liu

et al.

Viruses, Journal Year: 2023, Volume and Issue: 15(3), P. 596 - 596

Published: Feb. 21, 2023

More than 600 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of disease 2019 (COVID-19). In particular, new waves COVID-19 caused by emerging SARS-CoV-2 variants pose health risks to global population. Nanotechnology has developed excellent solutions combat virus pandemic, such as ACE2-based nanodecoys, nanobodies, nanovaccines, and drug nanocarriers. Lessons learned strategies during this battle against may also serve inspiration for developing nanotechnology-based other infectious diseases their future.

Language: Английский

Improving the circulation time and renal therapeutic potency of extracellular vesicles using an endogenous ligand binding strategy DOI
Shuyun Liu,

Ke Lv,

Yizhuo Wang

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 352, P. 1009 - 1023

Published: Nov. 16, 2022

Language: Английский

Citations

17
Decellularized tendon scaffolds loaded with collagen targeted extracellular vesicles from tendon-derived stem cells facilitate tendon regeneration DOI
Jing Cui, Yanjing Zhang, Xuan Li

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 360, P. 842 - 857

Published: July 25, 2023

Language: Английский

Citations

10
Nebulized M2 macrophage-derived nanovesicles for the treatment of explosion-induced acute lung injury DOI

Linqiang Tian,

Jie Jin,

Feng Lai

et al.

Journal of Colloid and Interface Science, Journal Year: 2025, Volume and Issue: unknown, P. 137381 - 137381

Published: March 1, 2025

Language: Английский

Citations

0
Naringenin regulates cigarette smoke extract-induced extracellular vesicles from alveolar macrophage to attenuate the mouse lung epithelial ferroptosis through activating EV miR-23a-3p/ACSL4 axis DOI
Weiyang Fan,

Ziyan Xu,

Jiashuo Zhang

et al.

Phytomedicine, Journal Year: 2023, Volume and Issue: 124, P. 155256 - 155256

Published: Dec. 10, 2023

Language: Английский

Citations

9
Biomimetic Nanotechnology for SARS-CoV-2 Treatment DOI Creative Commons
Shuo Li, Xue Liu, Gang Liu

et al.

Viruses, Journal Year: 2023, Volume and Issue: 15(3), P. 596 - 596

Published: Feb. 21, 2023

More than 600 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of disease 2019 (COVID-19). In particular, new waves COVID-19 caused by emerging SARS-CoV-2 variants pose health risks to global population. Nanotechnology has developed excellent solutions combat virus pandemic, such as ACE2-based nanodecoys, nanobodies, nanovaccines, and drug nanocarriers. Lessons learned strategies during this battle against may also serve inspiration for developing nanotechnology-based other infectious diseases their future.

Language: Английский

Citations

8